Botulinum neurotoxin products, also known as Botox, are considered safe for cosmetic use when administered in clinical settings. Unlicensed and off-label use of these products have been reported to cause severe and potentially fatal illness.
In August 2023, the Wyoming Department of Health was notified of a person who tested positive for leptospirosis, the first case reported in the state since 1983.
During June-October 2023, a cluster of early neonatal enterovirus infections caused by coxsackie virus B4/5 using nasopharyngeal virus polymerase chain reaction (PCR) testing.